pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·57m ago·1 min read
save

House passes stopgap bill to block White House plan for political control of federal research grants

Sep 1, 2026·read at STAT ↗RegulatoryNeutral

The House approved a temporary funding measure that blocks a White House proposal to let political appointees oversee federal research grants.

The measure passed 370‑48 and mirrors a Senate bill passed a month earlier, now awaiting the president’s signature.

The funding bill only extends government operations until Dec. 11, after which the ban on the grant‑control policy will expire.

The action aims to prevent politicization of research funding ahead of the midterm elections and avoid a shutdown.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: House votes to temporarily block Trump plan to politicize federal grants”

read at STAT ↗
471 words · retrieved 36m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.
topics
ImmunologyOncologyRare DiseaseVaccine

related stories

  • 4h agoGSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modalityBioSpace
  • 4h agoCellares trims workforce again, laying off 68 in New JerseyBioSpace
  • 2d agoSTAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s WainuaSTAT
  • 4d agoBioNTech halts mid-stage trial of personalized mRNA vaccine in colorectal cancerBioSpace
  • 4d agoSTAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watchingSTAT